Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neurodegenerative diseases
Biotech
GSK pens $2.5B pact for ABL's blood-brain barrier-bypassing tech
GSK has continued to flesh out its neuroscience strategy with a $2.5 billion deal to use a South Korean biotech to bypass the blood-brain barrier.
James Waldron
Apr 7, 2025 7:00am
Investment firm secures $250M to help fund dementia drug R&D
Mar 20, 2025 2:53pm
Oligomerix small molecule tamps down tau tangles in mice
Mar 14, 2025 12:30pm
Oligonucleotide stops gene expansion driving Huntington's: study
Feb 12, 2025 2:00pm
Hormone therapies help mice with ALS get better sleep: study
Jan 29, 2025 2:00pm
Tenvie takes off with $200M, assets and exec from Denali
Jan 8, 2025 8:00am
